Director at Justus Liebig University Giessen, Germany
Prof. Dr. Florian Martin Erich Wagenlehner is an eminent clinician-scientist and academic leader in the fields of urology, pediatric urology, and andrology. Currently serving as Director of the Clinic of Urology, Pediatric Urology, and Andrology at Justus Liebig University Giessen, Germany, he has built a distinguished career that integrates clinical excellence with cutting-edge research. His academic journey and professional achievements highlight his commitment to advancing the understanding and treatment of urogenital infections, antibiotic resistance, and male reproductive health. With more than 490 PubMed-indexed publications and an h-index of 77, his scientific contributions have significantly influenced clinical practice worldwide. Prof. Wagenlehner has led numerous national and international research programs, coordinated multi-center clinical trials, and pioneered new diagnostic approaches. His expertise is widely recognized through memberships in leading medical societies, editorial contributions, and prestigious awards. He continues to inspire the medical community with his dedication to translational research and patient care.
profile
orcid I scopus I Google scholar
Education
Prof. Dr. Florian Wagenlehner pursued his medical studies in Germany, where he built a strong foundation in clinical medicine and research methodology. He specialized in urology, pediatric urology, and andrology, combining rigorous academic training with clinical practice to develop expertise across these disciplines. Over the years, his educational pathway was shaped by both structured clinical residencies and continuous involvement in academic research, particularly in urogenital infections and antibiotic resistance. His professional growth was further enriched through collaborations with international institutions, such as the Monash University–Giessen International Research Training Group, where he contributed to cross-border studies on prostatitis, testis cancer, and reproductive health. His deep engagement in medical education is reflected in his academic role at Justus Liebig University Giessen, where he has served as professor since 2016. Through mentoring, lecturing, and supervising research, he has trained future generations of clinicians and scientists while expanding the global understanding of infection-related urological diseases.
Experience
Prof. Wagenlehner has extensive professional experience as both a clinician and researcher. He has served as Professor of Urology, Pediatric Urology, and Andrology at Justus Liebig University Giessen, where he also directs the University Hospital’s Clinic of Urology. His expertise bridges clinical care and translational science, with a strong focus on urogenital infections, antimicrobial resistance, and male reproductive health. He has coordinated and participated in over 40 clinical trials, spanning phases I to III, including investigations of novel antibiotics for urinary tract infections. His experience extends to leading national and international research consortia, serving as speaker for large-scale DFG-funded programs such as BARICADE, and contributing to International Research Training Groups with Monash University. Beyond academia, he has collaborated extensively with the pharmaceutical and biotech industry on consultancy and research projects. His leadership in developing diagnostic tools, evidence-based treatment guidelines, and clinical innovations underscores his role as a global authority.
Professional Development
Prof. Wagenlehner’s professional development reflects a consistent dedication to excellence in clinical practice, research, and academic leadership. Early in his career, he developed expertise in managing complex urological disorders, gradually focusing on infectious diseases of the urogenital tract. He has since expanded his portfolio by integrating molecular biology, microbiology, and clinical pharmacology into urological research. His participation in prestigious DFG-funded initiatives, including International Research Training Groups with Monash University, allowed him to gain international exposure and foster collaborations that strengthened his scientific output. Over the years, he has also assumed leadership roles in professional societies such as the European Association of Urology and the Paul Ehrlich Society, which further broadened his influence in guideline development and policy-making. His continuous professional growth is also marked by extensive publication, mentorship, and innovation in diagnostic methodology. These experiences have shaped him into a highly respected global leader in urology and infectious disease research.
Skills & Expertise
Prof. Wagenlehner possesses a unique combination of clinical, scientific, and leadership skills. His expertise lies primarily in urology, pediatric urology, and andrology, with specialization in urinary tract infections, chronic prostatitis, reproductive health, and prostate cancer. A recognized authority on antibiotic resistance, he has conducted groundbreaking translational research and clinical trials that influence treatment guidelines globally. His scientific acumen is evidenced by over 490 PubMed-indexed publications and a strong citation profile. Beyond clinical and research expertise, he has notable skills in international collaboration, having coordinated multi-center research programs and contributed to global consortia. He is also experienced in developing diagnostic tools, exemplified by his authorship of the Acute Cystitis Symptom Score (ACSS). His ability to translate scientific discovery into clinical practice is complemented by his mentorship and teaching roles. Prof. Wagenlehner’s balanced skill set enables him to bridge patient care, innovation, and policy development, making him a leader in his discipline.
Research Interests
Prof. Wagenlehner’s research focuses on understanding and managing urogenital infections, antibiotic resistance, and male reproductive health. He has spearheaded large-scale projects investigating bacterial renal infections, chronic prostatitis, testicular cancer, and the role of inflammatory pathways in male infertility. As speaker of the DFG Research Group BARICADE, he explores host-pathogen interactions in pyelonephritis, integrating pharmacokinetics, pharmacodynamics, and immune response parameters. His longstanding collaboration with Monash University through International Research Training Groups has advanced knowledge in reproductive immunology, chronic inflammation, and benign prostatic hyperplasia. Another key focus has been translational studies, bridging molecular insights with clinical applications, and developing individualized disease profiles. His role in over 40 clinical trials—many testing novel antibiotics—demonstrates his leadership in bringing innovative treatments to patients. Additionally, his work on guideline development and diagnostic scoring tools highlights his commitment to improving standards of care. His research ultimately aims to advance personalized medicine in urology and infectious diseases.
Awards
Prof. Wagenlehner’s contributions have been recognized with numerous national and international awards. Early in his career, he received the M. Ohkoshi Award from the International Society of Antimicrobial Chemotherapy , followed by the prestigious Ignaz Philipp Semmelweis Prize for excellence in infection research. His scientific leadership has been supported by competitive research grants from the Paul Ehrlich Society and the British Society for Antimicrobial Chemotherapy, acknowledging the global relevance of his work on antibiotic resistance and urogenital infections. He was appointed Honorary Member of the Swedish Urology Association, a testament to his international impact and reputation. In addition, he has contributed to more than 20 consultancy and industry projects, reflecting recognition from both academia and industry. His extensive publication record, with nearly 500 indexed articles and high citation metrics, further cements his standing as a leading authority. Collectively, these recognitions highlight his influence on clinical practice and scientific progress.
Publication Top Notes
Title: Complicated urinary tract infections in adults
Year: 2009
Citations: ~1,800
Title: Diagnosis and management for urinary tract infections and prostatitis in men
Year: 2011
Citations: ~1200
Title: New strategies in urinary tract infection management
Year: 2018
Citations: 1000
Title: Urogenital infections and antibiotic resistance overview
Year: 2007
Citations:~900
Title: Antimicrobial resistance in urinary tract pathogens: global trends
Year: 2012
Citations: ~850
Title: Acute cystitis symptom score (ACSS): validation study
Year: 2015
Citations: ~600
Title: Guidelines for urological infections (EAU)
Year: 2014
Citations: ~550
Title: Antibiotic stewardship in urology
Year: 2019
Citations: ~400
Conclusion
Prof. Wagenlehner’s prolific research, clinical trial leadership, and impactful innovations make him a highly deserving candidate for the Best Researcher Award. His global reputation, scientific contributions, and dedication to advancing clinical practice position him as not only a leader in urology and microbiology but also as an influential figure shaping future standards of infectious disease management.